GTCM
Gyon Technologies Capital Management Portfolio holdings
AUM
$267M
This Quarter Return
+1.76%
1 Year Return
-11.59%
3 Year Return
+41.48%
5 Year Return
–
10 Year Return
–
AUM
$371M
AUM Growth
+$371M
(+22%)
Cap. Flow
+$64.5M
Cap. Flow
% of AUM
17.37%
Top 10 Holdings %
Top 10 Hldgs %
12.07%
Holding
522
New
181
Increased
107
Reduced
74
Closed
160
Top Buys
| 1 |
Microsoft
MSFT
|
$5.06M |
| 2 |
TJX Companies
TJX
|
$4.24M |
| 3 |
AstraZeneca
AZN
|
$4.14M |
| 4 |
Canadian National Railway
CNI
|
$4.11M |
| 5 |
American International
AIG
|
$3.61M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$3.51M |
| 2 |
PayPal
PYPL
|
$3.48M |
| 3 |
Acuity Brands
AYI
|
$3.39M |
| 4 |
Pfizer
PFE
|
$3.25M |
| 5 |
Meta Platforms (Facebook)
META
|
$2.98M |
Sector Composition
| 1 | Financials | 23.31% |
| 2 | Technology | 18.47% |
| 3 | Healthcare | 15.14% |
| 4 | Industrials | 12.9% |
| 5 | Consumer Discretionary | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MGIC Investment
MTG
$6.42B
| $2.11M | 0.57% |
141,176
+14,474
| +11% | +$217K |
|
|
BPMC
52
DELISTED
Blueprint Medicines
BPMC
| $2.11M | 0.57% |
+20,495
| New | +$2.11M |
|
53
WESCO International
WCC
$10.7B
| $2.1M | 0.57% |
+18,213
| New | +$2.1M |
|
54
Cytokinetics
CYTK
$4.23B
| $2.06M | 0.56% |
57,748
+6,764
| +13% | +$242K |
|
55
Academy Sports + Outdoors
ASO
$3.56B
| $2.06M | 0.55% |
+51,442
| New | +$2.06M |
|
|
MCFE
56
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $2.03M | 0.55% |
+91,912
| New | +$2.03M |
|
57
Merck
MRK
$210B
| $2.03M | 0.55% |
26,983
-2,237
| -8% | -$168K |
|
58
SPDR S&P 500 ETF Trust
SPY
$658B
| $2.03M | 0.55% |
4,722
+395
| +9% | +$169K |
|
59
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $2M | 0.54% |
29,023
+107
| +0.4% | +$7.37K |
|
60
Twilio
TWLO
$16.2B
| $1.97M | 0.53% |
6,184
+4,966
| +408% | +$1.58M |
|
61
Travere Therapeutics
TVTX
$1.56B
| $1.95M | 0.52% |
+80,275
| New | +$1.95M |
|
62
Varonis Systems
VRNS
$6.61B
| $1.94M | 0.52% |
31,828
+25,904
| +437% | +$1.58M |
|
63
Celldex Therapeutics
CLDX
$1.47B
| $1.93M | 0.52% |
+35,764
| New | +$1.93M |
|
64
Altice USA
ATUS
$1.1B
| $1.92M | 0.52% |
+92,526
| New | +$1.92M |
|
65
FirstEnergy
FE
$25.2B
| $1.91M | 0.52% |
53,712
+30,265
| +129% | +$1.08M |
|
66
Open Lending Corp
LPRO
$249M
| $1.89M | 0.51% |
+52,466
| New | +$1.89M |
|
67
W.R. Berkley
WRB
$27.2B
| $1.87M | 0.5% |
+25,515
| New | +$1.87M |
|
68
PROG Holdings
PRG
$1.39B
| $1.83M | 0.49% |
43,621
+7,146
| +20% | +$300K |
|
69
AbbVie
ABBV
$372B
| $1.83M | 0.49% |
+16,951
| New | +$1.83M |
|
70
Performance Food Group
PFGC
$15.9B
| $1.78M | 0.48% |
38,394
+29,098
| +313% | +$1.35M |
|
71
Medtronic
MDT
$119B
| $1.78M | 0.48% |
14,179
-8,973
| -39% | -$1.12M |
|
72
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.77M | 0.48% |
+92,385
| New | +$1.77M |
|
73
Criteo
CRTO
$1.3B
| $1.73M | 0.47% |
+47,174
| New | +$1.73M |
|
74
Hershey
HSY
$37.3B
| $1.71M | 0.46% |
10,089
+2,211
| +28% | +$374K |
|
75
Allegion
ALLE
$14.6B
| $1.69M | 0.45% |
12,769
+5,720
| +81% | +$756K |
|